Franklin, Aimee V <br/><br/>
Glycogen synthase kinase-3 inhibitors reverse deficits in long-term potentiation and cognition in fragile X mice.  [electronic resource] 

 -  Biological psychiatry  Feb 2014 
 - 198-206 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1873-2402 
<br/><br/><label>Standard No.: </label>10.1016/j.biopsych.2013.08.003  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Cognition--drug effects<br/>Cognition Disorders--drug therapy<br/>Disease Models, Animal<br/>Disks Large Homolog 4 Protein<br/>Electric Stimulation<br/>Excitatory Amino Acid Antagonists--pharmacology<br/>Fragile X Mental Retardation Protein--genetics<br/>Fragile X Syndrome--complications<br/>Glycogen Synthase Kinase 3--antagonists & inhibitors<br/>Guanylate Kinases--metabolism<br/>Hippocampus--pathology<br/>In Vitro Techniques<br/>Lithium Chloride--pharmacology<br/>Long-Term Potentiation--drug effects<br/>Membrane Proteins--metabolism<br/>Mice<br/>Mice, Transgenic<br/>Patch-Clamp Techniques<br/>Protein Kinase Inhibitors--pharmacology<br/>Synapses--drug effects